Hyperpolarized 13C Metabolic MRI of the Human Heart

Rationale: Altered cardiac energetics is known to play an important role in the progression toward heart failure. A noninvasive method for imaging metabolic markers that could be used in longitudinal studies would be useful for understanding therapeutic approaches that target metabolism. Objective: To demonstrate the first hyperpolarized 13C metabolic magnetic resonance imaging of the human heart. Methods and Results: Four healthy subjects underwent conventional proton cardiac magnetic resonance imaging followed by 13C imaging and spectroscopic acquisition immediately after intravenous administration of a 0.1 mmol/kg dose of hyperpolarized [1-13C]pyruvate. All subjects tolerated the procedure well with no adverse effects reported ≤1 month post procedure. The [1-13C]pyruvate signal appeared within the chambers but not within the muscle. Imaging of the downstream metabolites showed 13C-bicarbonate signal mainly confined to the left ventricular myocardium, whereas the [1-13C]lactate signal appeared both within the chambers and in the myocardium. The mean 13C image signal:noise ratio was 115 for [1-13C]pyruvate, 56 for 13C-bicarbonate, and 53 for [1-13C]lactate. Conclusions: These results represent the first 13C images of the human heart. The appearance of 13C-bicarbonate signal after administration of hyperpolarized [1-13C]pyruvate was readily detected in this healthy cohort (n=4). This shows that assessment of pyruvate metabolism in vivo in humans is feasible using current technology. Clinical Trial Registration: URL: https://www.clinicaltrials.gov. Unique identifier: NCT02648009.

[1]  Neil Clarke,et al.  Dynamic nuclear polarization polarizer for sterile use intent , 2011, NMR in biomedicine.

[2]  Michael A. Burke,et al.  Targeting myocardial substrate metabolism in heart failure: potential for new therapies , 2012, European journal of heart failure.

[3]  G K Radda,et al.  Phosphorus NMR studies on perfused heart. , 1977, Biochemical and biophysical research communications.

[4]  L. Opie,et al.  Metabolic mechanisms in heart failure. , 2007, Circulation.

[5]  G. Radda,et al.  In vivo assessment of pyruvate dehydrogenase flux in the heart using hyperpolarized carbon-13 magnetic resonance , 2008, Proceedings of the National Academy of Sciences.

[6]  Torsten Doenst,et al.  Cardiac Metabolism in Heart Failure: Implications Beyond ATP Production , 2013, Circulation research.

[7]  S. Neubauer,et al.  Pyruvate dehydrogenase as a therapeutic target for obesity cardiomyopathy , 2016, Expert opinion on therapeutic targets.

[8]  Graham A Wright,et al.  Rapid multislice imaging of hyperpolarized 13C pyruvate and bicarbonate in the heart , 2010, Magnetic resonance in medicine.

[9]  H. Taegtmeyer,et al.  Adaptation and maladaptation of the heart in diabetes: Part I: general concepts. , 2002, Circulation.

[10]  K. Brindle,et al.  Kinetic Modeling of Hyperpolarized 13C Label Exchange between Pyruvate and Lactate in Tumor Cells* , 2011, The Journal of Biological Chemistry.

[11]  Peter Magnusson,et al.  Cardiac metabolism measured noninvasively by hyperpolarized 13C MRI , 2008, Magnetic resonance in medicine.

[12]  M. Chandler,et al.  Energy Metabolism in the Normal and Failing Heart: Potential for Therapeutic Interventions , 2002, Heart Failure Reviews.

[13]  Albert P. Chen,et al.  Reproducibility study for free‐breathing measurements of pyruvate metabolism using hyperpolarized 13C in the heart , 2013, Magnetic resonance in medicine.

[14]  J. Ardenkjær-Larsen,et al.  Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[15]  K. Clarke,et al.  Increasing Pyruvate Dehydrogenase Flux as a Treatment for Diabetic Cardiomyopathy: A Combined 13C Hyperpolarized Magnetic Resonance and Echocardiography Study , 2015, Diabetes.

[16]  D. Gadian,et al.  Studies of metabolism in the isolated, perfused rat heart using 13C NMR , 1981, FEBS letters.

[17]  Craig R. Malloy,et al.  Hyperpolarized 13C allows a direct measure of flux through a single enzyme-catalyzed step by NMR , 2007, Proceedings of the National Academy of Sciences.

[18]  Kieran Clarke,et al.  Hyperpolarized Magnetic Resonance: A Novel Technique for the In Vivo Assessment of Cardiovascular Disease , 2011, Circulation.

[19]  R. Cooksey,et al.  Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. , 2004, Diabetes.

[20]  Albert P. Chen,et al.  Hyperpolarized 13C magnetic resonance reveals early- and late-onset changes to in vivo pyruvate metabolism in the failing heart , 2012, European journal of heart failure.

[21]  D. Tyler,et al.  Clinical Implications of Cardiac Hyperpolarized Magnetic Resonance Imaging , 2013, Journal of Cardiovascular Magnetic Resonance.